New England Journal of Medicine

Effectiveness of mRNA covid-19 vaccine among U.S. Health care personnel.  385. 2021

Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase.  385:1774-1785. 2021

Triple therapy for cystic fibrosis Phe508del-gating and -residual function genotypes.  385:815-825. 2021

Cabotegravir for HIV prevention in cisgender men and transgender women.  385:595-608. 2021

A trial of hyperimmune globulin to prevent congenital cytomegalovirus infection.  385:436-444. 2021

Safety and efficacy of single-dose Ad26.CoV2.s vaccine against covid-19.  384:2187-2201. 2021

HIV Infection - Screening, Diagnosis, and Treatment..  384:2131-2143. 2021

Final report of a trial of intensive versus standard blood-pressure control.  384:1921-1930. 2021

Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.  384:1613-1622. 2021

Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas.  384:1613-1622. 2021

Gestational diabetes - On broadening the diagnosis.  384:965-966. 2021

Baricitinib plus remdesivir for hospitalized adults with Covid-19.  384:795-807. 2021

Higher or lower hemoglobin transfusion thresholds for preterm infants.  383:2639-2651. 2020

SARS-CoV-2 transmission among marine recruits during quarantine.  383:2407-2416. 2020

Timing of initiation of renal-replacement therapy in acute kidney injury.  383:1796. 2020

The editorialist replies.  383:1692. 2020

Respiratory syncytial virus vaccination during pregnancy and effects in infants.  383:426-439. 2020

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.  383:334-346. 2020

Urate-lowering therapy and chronic kidney disease progression.  382:2567-2568. 2020

The impact of a pass/fail step 1 — A residency program director’s view.  382:2387-2389. 2020

Metoprolol for the Prevention of Exacerbations of COPD. Reply.  382:1375-1376. 2020

Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction.  382:1180-1183. 2020

Long-acting cabotegravir and rilpivirine after oral induction for HIV-1 infection.  382:1124-1135. 2020

Responding to Unprofessional Behavior by Trainees-A "just Culture" Framework.  382:773-777. 2020

Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation. Reply.  382:684. 2020

Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer.  381:2403-2415. 2019

Metoprolol for the prevention of acute exacerbations of COPD.  381:2304-2314. 2019

Ambient Air Pollution and Mortality in 652 Cities.  381:2073-2074. 2019

Case 36-2019: A 34-Year-Old Man with Dyspnea, Odynophagia, and Abdominal Pain..  381:2052-2061. 2019

Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele.  381:1809-1819. 2019

Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML.  381:1728-1740. 2019

Heatstroke.  381:1186. 2019

Oral selinexor-dexamethasone for triple-class refractory multiple myeloma.  381:727-738. 2019

The “All of Us” Research Program.  381:668-676. 2019

A Phase 3 randomized trial of voxelotor in sickle cell disease.  381:509-519. 2019

Ibrutinib–rituximab or chemoimmunotherapy for chronic lymphocytic leukemia.  381:432-443. 2019

Hazardous chemical emergencies and poisonings.  381:392. 2019

Rituximab or cyclosporine in the treatment of membranous nephropathy.  381:36-46. 2019

Weak and Winded.  381:76-82. 2019

Five-year outcomes of gastric bypass in adolescents as compared with adults.  380:2136-2145. 2019

Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation.  380:1509-1524. 2019

Bag-mask ventilation during tracheal intubation of critically ill adults.  380:811-821. 2019

Organ donation and drug intoxication-related deaths in the United States.  380:597-599. 2019

Dapagliflozin and cardiovascular outcomes in type 2 diabetes.  380:347-357. 2019

Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL.  379:2517-2528. 2018

Alirocumab and cardiovascular outcomes after acute coronary syndrome.  379:2097-2107. 2018

Effect of genetic diagnosis on patients with previously undiagnosed disease.  379:2131-2139. 2018

Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea.  379:1835-1845. 2018

Phase 2b controlled trial of M72/AS01E vaccine to prevent tuberculosis.  379:1621-1634. 2018

VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles.  379:1612-1620. 2018

VX-659-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles.  379:1599-1611. 2018

Abortion "reversal"-Legislating without evidence.  379:1491-1493. 2018

Phase 2 trial of ibudilast in progressive multiple sclerosis.  379:846-855. 2018

Radical changes for reproductive health care - Proposed regulations for title X.  379:706-707. 2018

Labor induction versus expectant management in low-risk nulliparous women.  379:513-523. 2018

A phase 3 trial of l-glutamine in sickle cell disease.  379:226-235. 2018

Procalcitonin-guided use of antibiotics for lower respiratory tract infection.  379:236-249. 2018

Inotersen treatment for patients with Hereditary transthyretin amyloidosis.  379:22-31. 2018

Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML.  378:2386-2398. 2018

Outpatient talc administration by indwelling pleural catheter for malignant effusion.  378:1313-1322. 2018

Cardiovascular safety of febuxostat or allopurinol in patients with gout.  378:1200-1210. 2018

Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.  378:195-196. 2018

Once-daily single-inhaler triple versus dual therapy in patients with COPD.  378:1671-1680. 2018

Tezacaftor–ivacaftor in residual-function heterozygotes with cystic fibrosis.  377:2024-2035. 2017

Romosozumab or alendronate for fracture prevention in women with osteoporosis.  377:1417-1427. 2017

Rivaroxaban with or without aspirin in stable cardiovascular disease.  377:1319-1330. 2017

Effects of anacetrapib in patients with atherosclerotic vascular disease.  377:1217-1227. 2017

Antiinflammatory therapy with canakinumab for atherosclerotic disease.  377:1119-1131. 2017

Cost-effectiveness of intensive versus standard blood-pressure control.  377:745-755. 2017

Effect of intensive blood-pressure treatment on patient-reported outcomes.  377:733-744. 2017

Subclinical hypothyroidism or hypothyroxinemia in pregnancy.  377:701. 2017

Health effects of overweight and obesity in 195 countries over 25 years.  377:13-27. 2017

Racial disparities in risks of stroke.  376. 2017

KIT inhibition by imatinib in patients with severe refractory asthma.  376:1911-1920. 2017

Crizanlizumab in sickle cell disease.  376:1795-1796. 2017

Evolocumab and clinical outcomes in patients with cardiovascular disease.  376:1713-1722. 2017

Cardiovascular efficacy and safety of bococizumab in high-risk patients.  376:1527-1539. 2017

Dyskeratosis congenita.  376:1460. 2017

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor..  376:1131-1140. 2017

Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy.  376:815-825. 2017

Survival and neurodevelopmental outcomes among periviable infants.  376:617-628. 2017

The authors reply.  376:598-599. 2017

Crizanlizumab for the prevention of pain crises in sickle cell disease.  376:429-439. 2017

The authors reply.  376:182. 2017

Permanent supportive housing for homeless people - Reframing the debate.  375:2115-2117. 2016

Effect of HIV antibody VRC01 on viral rebound after treatment interruption.  375:2037-2050. 2016

Acute pancreatitis.  375:1972-1981. 2016

The authors reply.  375:2006-2007. 2016

The authors reply.  375:1906. 2016

A randomized trial of long-term oxygen for COPD with moderate desaturation.  375:1617-1627. 2016

Medical Considerations before International Travel..  375:e32. 2016

The authors reply.  375:e232. 2016

Adjunctive azithromycin prophylaxis for cesarean delivery.  375:1231-1241. 2016

Genital herpes.  375:666-674. 2016

Randomized trial of thymectomy in myasthenia gravis.  375:511-522. 2016

Stenting versus surgery for carotid stenosis.  375:604-605. 2016

Management of Advanced Head and Neck Cancer.  375:492. 2016

The authors reply.  375:492-493. 2016

Medical considerations before international travel.  375:247-260. 2016

The authors reply.  375:288-289. 2016

Azithromycin versus doxycycline for Chlamydia: The authors reply.  374:1787. 2016

Antenatal betamethasone for women at risk for late preterm delivery.  374:1311-1320. 2016

Long-term results of stenting versus endarterectomy for carotid-artery stenosis.  374:1021-1031. 2016

Survival benefit with kidney transplants from HLA-incompatible live donors.  374:940-950. 2016

Reduction in late mortality among 5-year survivors of childhood cancer.  374:833-842. 2016

Weekly vs. every-3-week paclitaxel and carboplatin for ovarian cancer.  374:738-748. 2016

A multinational trial of prasugrel for sickle cell vaso-occlusive events.  374:625-635. 2016

Effects of testosterone treatment in older men.  374:611-624. 2016

Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.  374:113-123. 2016

Azithromycin versus doxycycline for urogenital chlamydia trachomatis infection.  373:2512-2521. 2015

Trial of continuous or interrupted chest compressions during CPR.  373:2203-2214. 2015

A randomized trial of intensive versus standard blood-pressure control.  373:2103-2116. 2015

Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1.  373:714-725. 2015

Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1.  373:705-713. 2015

A randomized trial of intrapartum fetal ECG ST-segment analysis.  373:632-641. 2015

Community-acquired pneumonia requiring hospitalization among U.S. adults.  373:415-427. 2015

Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR.  373:220-231. 2015

Fibrosis--A Common Pathway to Organ Injury and Failure.  373:96. 2015

Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas.  372:2481-2498. 2015

Ezetimibe added to statin therapy after acute coronary syndromes.  372:2387-2397. 2015

The authors reply.  372:2463. 2015

Less-tight versus tight control of hypertension in pregnancy.  372:2366-2368. 2015

The authors reply.  372:2367-2368. 2015

A longitudinal study of bullying of sexual-minority youth.  372:1872-1874. 2015

Between-hospital variation in treatment and outcomes in extremely preterm infants.  372:1801-1811. 2015

A history lesson.  372:1360-1364. 2015

Fibrosis-a common pathway to organ injury and failure.  372:1138-1149. 2015

Why is there no generic insulin? historical origins of a modern problem.  372:1171-1175. 2015

Valganciclovir for symptomatic congenital cytomegalovirus disease.  372:933-943. 2015

Community-acquired pneumonia requiring hospitalization among U.S. children.  372:835-845. 2015

Smoking and Mortality-Beyond Established Causes.  372:631-640. 2015

Preventing HIV in women - Still trying to find their voice.  372:564-566. 2015

Preventing HIV in women--still trying to find their VOICE.  372:564-566. 2015

Tenofovir-based preexposure prophylaxis for HIV infection among African women.  372:509-518. 2015

Causes and timing of death in extremely premature infants from 2000 through 2011.  372:331-340. 2015

The amyloidogenic V122I transthyretin variant in elderly black Americans.  372:21-29. 2015

Novel mutations in a patient with ALK-rearranged lung cancer: To the editor.  371:1655-1656. 2014

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.  371:1005-1015. 2014

Low sodium intake - Cardiovascular health benefit or risk?.  371:677-679. 2014

Transplantation of Severe Combined Immunodeficiency in 240 Patients from 2000-2009: A Report from the Primary Immune Deficiency Treatment Consortium of North America..  371:434--446. 2014

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.  372:711-723. 2014

A controlled trial of renal denervation for resistant hypertension.  370:1393-1401. 2014

A novel potential therapy for HSV.  370:273-274. 2014

Oral GS-5806 activity in a respiratory syncytial virus challenge study.  371:711-722. 2014

Prenatal whole-genome sequencing - Is the quest to know a fetus's future ethical?.  370:195-197. 2014

Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.  370:2093-2101. 2014

Secukinumab in plaque psoriasis - Results of two phase 3 trials.  371:326-338. 2014

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.  370:2201-2210. 2014

Stenting for renal-artery stenosis [3].  370:1853. 2014

Fungal infections associated with contaminated methylprednisolone injections..  369:1598-1609. 2013

Results of the Two Incidence Screenings in the National Lung Screening Trial.  369:920-931. 2013

Oxygen-saturation targets in extremely preterm infants.  368:1949-1950. 2013

Continuous renal-replacement therapy for acute kidney injury..  368:1160-1161. 2013

Myths, presumptions, and facts about obesity.  368:446-454. 2013

A pharmacogenetic versus a clinical algorithm for warfarin dosing.  369:2283-2293. 2013

Abatacept in B7-1-positive proteinuric kidney disease.  369:2416-2423. 2013

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.  369:2492-2503. 2013

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.  369:145-154. 2013

Edoxaban versus warfarin in patients with atrial fibrillation.  369:2093-2104. 2013

Fungal infections associated with contaminated methylprednisolone injections.  368:2495-2500. 2013

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.  369:1691-1703. 2013

MEdical progress: IgA nephropathy.  368:2402-2414. 2013

Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.  369:517-528. 2013

The authors reply.  369:2358-2359. 2013

Continuous renal-replacement therapy for acute kidney injury.  367:2505-2514. 2012

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.  367:2482-2494. 2012

Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial.  367:2495-2504. 2012

The authors reply.  367:2254-2255. 2012

Anticholinergic therapy vs. onabotulinumtoxinA for urgency urinary incontinence.  367:1803-1813. 2012

Linezolid for treatment of chronic extensively drug-resistant tuberculosis..  367:1508-1518. 2012

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.  367:1297-1309. 2012

Cutting family planning in Texas.  367:1179-1181. 2012

Pulmonary arterial enlargement and acute exacerbations of COPD.  367:913-921. 2012

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.  367:817-825. 2012

Racial and ethnic health disparities among fifth-graders in three cities.  367:735-745. 2012

Prospective trial of a pediatric ventricular assist device.  367:532-541. 2012

A midurethral sling to reduce incontinence after vaginal prolapse repair.  366:2358-2367. 2012

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.  366:2345-2357. 2012

A randomized trial of urodynamic testing before stress-incontinence surgery.  366:1987-1997. 2012

Vorapaxar in the secondary prevention of atherothrombotic events.  366:1404-1413. 2012

Lifestyle Change and Mobility in Obese Adults with Type 2 Diabetes.  366:1209-1217. 2012

Industry Support of CME - Are we at the tipping point?.  366:1069-1071. 2012

Intramuscular versus intravenous therapy for prehospital status epilepticus..  366:591-600. 2012

The authors reply.  366:90-91. 2012

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.  365:1663-1672. 2011

Constrictive bronchiolitis in soldiers [1].  365:1743-1745. 2011

Inducible apoptosis as a safety switch for adoptive cell therapy.  365:1673-1683. 2011

The authors reply.  365:1746-1747. 2011

Oral acyclovir suppression and neurodevelopment after neonatal herpes.  365:1284-1292. 2011

Stenting versus aggressive medical therapy for intracranial arterial stenosis.  365:993-1003. 2011

A Trial of an Impedance Threshold Device in Out-of-Hospital Cardiac Arrest.  365:798-806. 2011

Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest.  365:787-797. 2011

Azithromycin for prevention of exacerbations of COPD.  365:689-698. 2011

The authors reply.  365:671-672. 2011

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening.  365:395-409. 2011

Bardoxolone methyl and kidney function in CKD with type 2 diabetes.  365:327-336. 2011

Desensitization in HLA-incompatible kidney recipients and survival.  365:318-326. 2011

The authors reply.  365:277-278. 2011

Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns.  364:2111-2118. 2011

Abiraterone and increased survival in metastatic prostate cancer.  364:1995-2005. 2011

Alemtuzumab induction in renal transplantation.  364:1909-1919. 2011

Dialysis catheters and recombinant tissue plasminogen activator.  364:1779-1780. 2011

NFKBIA deletion in glioblastomas.  364:627-637. 2011

In search of....  363:2249-2254. 2010

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.  363:1991-2003. 2010

The authors reply.  363:1285-1286. 2010

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.  363:620-628. 2010

Stenting versus endarterectomy for treatment of carotid-artery stenosis.  363:11-23. 2010

The authors reply.  362:2428. 2010

Retropubic versus Transobturator Midurethral Slings for Stress Incontinence.  362:2066-2076. 2010

Early CPAP versus surfactant in extremely preterm infants.  362:1970-1979. 2010

Target ranges of oxygen saturation in extremely preterm infants.  362:1959-1969. 2010

Stent graft or balloon angioplasty alone for dialysis-access grafts [6].  362:1939. 2010

Vitamins C and E to prevent complications of pregnancy-associated hypertension.  362:1282-1291. 2010

Newborn-care training and perinatal mortality in developing countries.  362:614-623. 2010

Gene therapy for color blindness.  361:2483. 2009

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.  361:1945-1952. 2009

Functional status of elderly adults before and after initiation of dialysis.  361:1539-1547. 2009

A multicenter, randomized trial of treatment for mild gestational diabetes.  361:1339-1348. 2009

A weighty matter - Lifting after breast cancer.  361:710-711. 2009

C3 polymorphisms and outcomes of renal allografts.  360:2477-2479. 2009

Medicare nonpayment, hospital falls, and unintended consequences.  360:2390-2393. 2009

Effect of dipyridamole plus aspirin on hemodialysis graft patency.  360:2191-2201. 2009

Effect of early versus deferred antiretroviral therapy for HIV on survival.  360:1815-1826. 2009

Efficacy of esomeprazole for treatment of poorly controlled asthma.  360:1487-1499. 2009

The authors reply.  360:1570-1571. 2009

Mortality results from a randomized prostate-cancer screening trial.  360:1310-1319. 2009

Racial differences in incident heart failure among young adults.  360:1179-1190. 2009

Vaccine prevention of maternal cytomegalovirus infection.  360:1191-1199. 2009

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data.  360:753-764. 2009

Letter to the editors.  360:540-541. 2009

Weight loss to treat urinary incontinence in overweight and obese women.  360:481-490. 2009

The neurontin legacy - Marketing through misinformation and manipulation.  360:103-106. 2009

Timing of elective repeat cesarean delivery at term and neonatal outcomes.  360:111-120. 2009

The author replies.  359:2293-2294. 2008

Aggressive vs. conservative phototherapy for infants with extremely low birth weight.  359:1885-1896. 2008

Medical progress: Uric acid and cardiovascular risk.  359:1811-1821. 2008

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.  359:1631-1633. 2008

Subgroup analyses of Maraviroc in previously treated R5 HIV-1 infection.  359:1442-1455. 2008

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.  359:584-592. 2008

Malaria prevention in short-term travelers.  359:603-612. 2008

Safety and efficacy of gene transfer for Leber's congenital amaurosis.  358:2240-2248. 2008

Hyperglycemia and adverse pregnancy outcomes.  358:1991-2002. 2008

MicroRNA expression in cytogenetically normal acute myeloid leukemia.  358:1919-1928. 2008

The authors reply.  358:1303-1304. 2008

The new age of molecular diagnostics for microbial agents.  358:988-989. 2008

Incidental findings on brain MRI [7].  358:853-855. 2008

Focus on research: Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina.  358:552-554. 2008

Mapping the atrioventricular node.  357:2706. 2007

Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.  357:2237-2247. 2007

Mirror therapy for phantom limb pain [15].  357:2206-2207. 2007

The authors reply [8].  357:2202-2203. 2007

Teriparatide or alendronate in glucocorticoid-induced osteoporosis.  357:2028-2039. 2007

More on severe cutaneous reaction with radiotherapy and cetuximab [13].  357:1872-1873. 2007

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.  357:1301-1310. 2007

The tension between needing to improve care and knowing how to do it.  357:608-613. 2007

Weekend admission for myocardial infarction [11].  357:87. 2007

Anidulafungin versus fluconazole for invasive candidiasis.  356:2472-2482. 2007

Burch colposuspension versus fascial sling to reduce urinary stress incontinence.  356:2143-2155. 2007

Long-Term Effect of Diabetes and Its Treatment on Cognitive Function.  356:1842-1852. 2007

Retinal progenitor cells - Timing is everything.  356:1577-1579. 2007

Influence of computer-aided detection on performance of screening mammography.  356:1399-1409. 2007

Varicella-zoster vaccine for the prevention of herpes zoster.  356:1338-1343. 2007

Three Indonesian clusters of H5N1 virus infection in 2005.  355:2186-2194. 2006

Effect of ramipril on the incidence of diabetes.  355:1551-1562. 2006

The authors reply [8].  355:1176. 2006

Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure.  355:354-364. 2006

The authors and a colleague reply [11].  354:2187. 2006

The authors reply [13].  354:1851. 2006

Feasibility of treating prehypertension with an angiotensin-receptor blocker.  354:1685-1697. 2006

Abdominal sacrocolpopexy with burch colposuspension to reduce urinary stress incontinence.  354:1557-1566. 2006

Calcium plus vitamin D supplementation and the risk of colorectal cancer.  354:684-696. 2006

Calcium plus vitamin D supplementation and the risk of fractures.  354:669-683. 2006

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.  354:567-578. 2006

Spectrum of disease and relation to place of exposure among ill returned travelers.  354:119-130. 2006

The authors reply [2].  354:202-203. 2006

Molecular identification of bacteria associated with bacterial vaginosis.  353:1899-1911. 2005

Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.  353:1574-1584. 2005

Autoantibody signatures in prostate cancer.  353:1224-1235. 2005

Inhaled nitric oxide for premature infants with severe respiratory failure.  353:13-22. 2005

Cystic fibrosis.  352:2039. 2005

Cystic fibrosis.  352:1992-2001. 2005

Case 13-2005: A 48-year-old man with weakness of the limbs and multiple tumors of spinal nerves.  352:1800-1808. 2005

Azithromycin for the secondary prevention of coronary events.  352:1637-1645. 2005

Rivastigmine for dementia associated with Parkinson's disease..  352:1387. 2005

Personal digital educators.  352:860-862. 2005

U.K. controlled trial of intrapleural streptokinase for pleural infection.  352:865-874. 2005

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.  352:362-372. 2005

Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery.  351:2581-2589. 2004

Levodopa and the progression of parkinson’s disease.  351:2498-2508. 2004

Hyperkalemia after the Publication of RALES [1] (multiple letters).  351:2448-2450. 2004

Anti-interleukin-12 antibody for active Crohn's disease.  351:2069-2079. 2004

Syphilis control - A continuing challenge.  351:122-124. 2004

Genital Herpes.  350:1970-1977+2017. 2004

Postmenopausal Osteoporosis and Strontium Ranelate.  350:2001-2003. 2004

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.  350:1850-1861. 2004

Clinical practice. Genital herpes..  350:1970-1977. 2004

Transient Memory Impairment and Hallucinations Associated with Tolterodine Use [8].  349:2274-2275. 2003

The Rapid Development of Fluoroquinolone Resistance in M. tuberculosis [7].  349:1977-1978. 2003

Gentamicin-induced correction of CFTR, function in patients with cystic fibrosis and CFTR stop mutations.  349:1433-1441. 2003

Low-carbohydrate diets as compared with low-fat diets [2] (multiple letters).  349:1000-1002. 2003

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.  348:2379-2385. 2003

Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus.  348:2294-2303. 2003

A randomized trial of a low-carbohydrate diet for obesity.  348:2082-2090. 2003

Herpes zoster [8] (multiple letters).  348:2044-2045. 2003

Effect of dialysis dose and membrane flux in maintenance hemodialysis.  347:2010-2019. 2002

Herpes zoster.  347:340-346. 2002

Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants.  347:240-247. 2002

Voriconazole versus liposomal amphotericin B for empirical antifungal therapy [1] (multiple letters).  346:1745-1747. 2002

Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome.  346:1281-1286. 2002

Genes, microbes, and T cells - New therapeutic targets in Crohn's disease.  346:614-616. 2002

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.  346:225-234. 2002

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.  345:1444-1451. 2001

Long-term use of a left ventricular assist device for end-stage heart failure.  345:1435-1443. 2001

Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.  345:487-493. 2001

Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I [1] letters).  345:64-66. 2001

Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.  344:1366-1371. 2001

The continuing value of the Apgar score for the assessment of newborn infants.  344:467-471. 2001

Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I.  344:270-274. 2001

Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants.  344:95-101. 2001

Renal transplantation in black Americans.  343:1545-1552. 2000

Stroke in patients with asymptomatic internal-carotid-artery stenosis [4] (multiple letters).  343:1420-1421. 2000

The volume of primary angioplasty procedures and survival after acute myocardial infarction [4] (multiple letters).  343:1045. 2000

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.  343:522-529. 2000

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.  343:246-253. 2000

The volume of primary angioplasty procedures and survival after acute myocardial infarction.  342:1573-1580. 2000

Intrauterine infection and preterm delivery.  342:1500-1507. 2000

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.  342:998-1006. 2000

Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms.  342:829-835. 2000

Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis.  342:534-540. 2000

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin [1] (multiple letters).  341:762-763. 1999

Vitamin A supplementation for extremely-low-birth-weight infants.  340:1962-1968. 1999

Acute necrotizing pancreatitis.  340:1412-1417. 1999

Birth weight in relation to morbidity and mortality among newborn infants.  340:1234-1238. 1999

Mechanisms of Disease: Genetic disorders of renal electrolyte transport.  340:1177-1187. 1999

Cytomegalovirus retinitis - Evolving therapies in a new era.  340:1109-1110. 1999

Liposomal amphotericin b for empirical therapy in patients with persistent fever and neutropenia.  340:764-771. 1999

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.  339:1810-1816. 1998

Human cloning [5] (multiple letters).  339:1558-1559. 1998

Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension.  339:667-671. 1998

Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient.  339:444-449. 1998

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis.  339:292-299. 1998

Reperfusion for right ventricular infarction.  338:978-980. 1998

Low-dose aspirin to prevent preeclampsia in women at high risk.  338:701-705. 1998

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation.  338:161-165. 1998

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.  337:1576-1583. 1997

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.  337:141-147. 1997

Trial of calcium to prevent preeclampsia.  337:69-76. 1997

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome.  337:15-21. 1997

Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery.  336:92-99. 1997

Erratum: Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome (New England Journal of Medicine (1997) 337 (15-21)).  337:1557-1558. 1997

Current concepts: Evaluation of dementia.  335:330-336. 1996

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI) investigators.  335:217-225. 1996

Bacterial vaginosis and preterm birth [3].  334:1337-1339. 1996

Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass.  334:1023-1028. 1996

Breast cancer and other second neoplasms after childhood Hodgkin's disease.  334:745-751. 1996

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.  334:296-300. 1996

Late effects of treatment for childhood Hodgkin's disease [3].  335:352-355. 1996

Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.  333:1732-1736. 1995

A preliminary study of ritonavir, an inhibitor of hiv-1 protease, to treat hiv-1 infection.  333:1534-1540. 1995

A controlled study of adenoviral-vector–mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.  333:823-831. 1995

Long-term treatment of osteopetrosis with recombinant human interferon gamma.  332:1594-1599. 1995

Regeneration of t cells after chemotherapy.  332:1650-1652. 1995

Molecular diagnosis.  332:1499-1502. 1995

A randomized trial of care in a hospital medical unit especially designed to improve the functional outcomes of acutely ill older patients.  332:1338-1344. 1995

Hypertensive crisis since fdr – a partial victory.  332:1029-1030. 1995

Coronary angioplasty compared with bypass grafting.  332:888-890. 1995

Coronary angioplasty compared with bypass grafting..  332:889. 1995

HLA matching in renal transplantation.  332:752-753. 1995

Molecular medicine molecular diagnosis.  332:1218-1221. 1995

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia.  331:1325-1330. 1994

Hormonal treatment of postmenopausal women.  331:550. 1994

Performance of four computer-based diagnostic systems.  330:1792-1796. 1994

A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants.  330:1107-1113. 1994

What to do when zidovudine fails.  330:706-707. 1994

Liddle's Syndrome Revisited – A Disorder of Sodium Reabsorption in the Distal Tubule.  330:178-181. 1994

A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase.  329:1065-1072. 1993

Medicaid Coverage of Oral Rehydration Solutions.  329:211. 1993

The Affliction of Internal Medicine.  329:212. 1993

The Spring Meetings – Are They Dying?.  328:1645-1647. 1993

Antihypertensive Therapy – Efficacy and Quality of Life.  328:959-961. 1993

Hypothalamic-Pituitary Dysfunction after Radiation for Brain Tumors.  328:87-94. 1993

A Controlled Clinical Trial of Dichloroacetate for Treatment of Lactic Acidosis in Adults.  327:1564-1569. 1992

Acquired Syphilis in Adults.  327:959-961. 1992

Acyclovir: A Decade Later.  327:782-789. 1992

Congenital Cytomegalovirus Infection and Maternal Antibody Status.  327:495-496. 1992

Where Have All the Primary Care Applicants Gone?.  326:1778-1780. 1992

Where have all the primary care applicants gone?.  326:1778. 1992

Acyclovir in chickenpox.  326:1224-1226. 1992

Home monitoring of uterine activity.  326:1222-1224. 1992

Acquired syphilis in adults.  326:1060-1069. 1992

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group..  326:793-798. 1992

A controlled trial of fluconazole or amphotericin b to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.  326:793-798. 1992

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.  326:663-667. 1992

Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates.  326:161-166. 1992

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group..  326:83-89. 1992

Comparison of amphotericin b with fluconazole in the treatment of acute aids-associated cryptococcal meningitis.  326:83-89. 1992

Drug promotion and scientific exchange.  326:133-134. 1992

Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels.  325:1630-1634. 1991

A Controlled Trial of Acyclovir for Chickenpox in Normal Children.  325:1539-1544. 1991

A Comparison of Single-Dose Cefixime with Ceftriaxone as Treatment for Uncomplicated Gonorrhea.  325:1337-1341. 1991

Does It Prevent Prematurity?.  325:1374-1377. 1991

Primary hiv-1 infection.  325:733-735. 1991

Rapid loss of vertebral mineral density after renal transplantation.  325:544-550. 1991

Higgledy, piggledy?.  325:361-362. 1991

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants.  324:1005-1011. 1991

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.  324:954-960. 1991

Treatment of hypertensive crisis.  324:992-994. 1991

A Controlled Trial Comparing Vidarabine with Acyclovir in Neonatal Herpes Simplex Virus Infection.  324:444-449. 1991

Predictors of morbidity and mortality in neonates with herpes simplex virus infections.  324:450-454. 1991

Higgledy, piggledy.  324:497. 1991

Cyclical etidronate treatment of osteoporosis.  323:1633-1635. 1990

Treatment of hypertensive crisis.  323:1177-1183. 1990

Aerosolized Amiloride for the Treatment of Lung Disease in Cystic Fibrosis.  323:996-998. 1990

Viral Encephalitis.  323:242-250. 1990

A Pilot Study of Aerosolized Amiloride for the Treatment of Lung Disease in Cystic Fibrosis.  322:1189-1194. 1990

A caution about the use of mri to diagnose spinal cord compression.  322:556-557. 1990

Aerosolized amiloride for the treatment of lung disease in cystic fibrosis (Reply).  323:997-998. 1990

Hypertension, Race, and Renal Insufficiency.  321:690-692. 1989

Adrenal Medullary Autografts in Patients with Parkinson's Disease.  321:324-327. 1989

Nosocomial Clostridium difficile Infections.  321:190. 1989

Two Plans for Universal Health Insurance.  321:114-119. 1989

The Hook Effect: High Concentrations of Prostate-Specific Antigen Giving Artifactually Low Values on One-Step Immunoassay.  320:1755-1756. 1989

A Randomized, Controlled Trial of Very Early Prophylactic Ligation of the Ductus Arteriosus in Babies Who Weighed 1000 g or Less at Birth.  320:1511-1516. 1989

Pressure Ulcers among the Elderly.  320:850-853. 1989

Renal Insufficiency in Treated Essential Hypertension.  320:684-688. 1989

Right Renal Trauma: A Side Effect of Biliary Lithotripsy.  320:739. 1989

Valvular Heart Disease in Systemic Lupus Erythematosus.  320:739-741. 1989

Cerebral Cavernous Malformations.  319:1414-1415. 1988

Diagnostic Yield of the Autopsy.  319:1095-1096. 1988

The Mortality Experience of Major-League Baseball Players.  319:1014-1015. 1988

Predictive Testing for Huntington's Disease Using Linked DNA Markers.  319:583-584. 1988

Cerebral Cavernous Malformations.  319:343-347. 1988

Falsification of Credentials by Applicants for Medical Staffs.  319:376-377. 1988

Screening for HIV Infection in Sexually Transmitted Disease Clinics.  319:242-243. 1988

Bedside Diagnosis of Systolic Murmurs.  318:1572-1578. 1988

Sonographic Identification of Down's Syndrome.  318:1399-1400. 1988

Diagnostic Yield of the Autopsy in a University Hospital and a Community Hospital.  318:1249-1254. 1988

The Mortality Experience of Major-League Baseball Players.  318:1278-1280. 1988

Thin Stage I Primary Cutaneous Malignant Melanoma.  318:1159-1162. 1988

Predictive Testing for Huntingtons Disease with Use of a Linked DNA Marker.  318:535-542. 1988

Human Immunodeficiency Virus Infection among Patients Attending Clinics for Sexually Transmitted Diseases.  318:197-203. 1988

Young Children as a Probable Source of Maternal and Congenital Cytomegalovirus Infection.  317:1539-1540. 1987

An ACTH Receptor on Human Mononuclear Leukocytes.  317:1266-1269. 1987

Chronic Recurrent Multifocal Osteomyelitis: Are Mycoplasmas Involved?.  317:510-511. 1987

Prolactin Levels after Pregnancy.  317:384-386. 1987

Young Children as a Probable Source of Maternal and Congenital Cytomegalovirus Infection.  316:1366-1370. 1987

The Case for the Use of Animals in Biomedical Research.  316:551-553. 1987

Hemophilus Influenzae Type B Disease in Children Vaccinated with Type B Polysaccharide Vaccine.  315:1584-1590. 1986

Hematologic Data in the Case Records.  315:1488-1489. 1986

Herpesvirus Infections of Pregnancy.  314:1255. 1986

Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody.  314:1236-1239. 1986

Biogenic Amines in the Rett Syndrome.  314:784. 1986

Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked Fluorescence.  314:403-408. 1986

Methyldopa and Reticuloendothelial Function.  314:248-249. 1986

Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis.  314:144-149. 1986

Asymptomatic Blood Donor with a False Positive HTLV-III Western Blot.  314:118. 1986

Lymphomatous All with Abnormalities of the Short Arm of Chromosome 9.  313:1611-1612. 1985

Herpesvirus Infections of Pregnancy: Herpes Simplex Virus and Varicella–Zoster Virus Infections.  313:1327-1330. 1985

Herpesvirus Infections of Pregnancy: Cytomegalovirus and Epstein–Barr Virus Infections.  313:1270-1274. 1985

Reduction of Biogenic Amine Levels in the Rett Syndrome.  313:921-924. 1985

Familial IgA Nephropathy.  313:186. 1985

Parvovirus Infection: Chance and Investigation.  313:111-112. 1985

Familial IgA Nephropathy: Evidence of an Inherited Mechanism of Disease.  312:202-208. 1985

Clonal Remission in Acute Leukemia.  311:922-923. 1984

Oral Levodopa in Heart Failure.  311:671-672. 1984

Predicting Relapse in Acute Asthma.  311:197-198. 1984

Treatment of Herpesvirus Infections.  310:654-655. 1984

Inability to Predict Relapse in Acute Asthma.  310:577-580. 1984

Teaching Clinical Medicine by Iterative Hypothesis Testing.  310:600-601. 1984

Percutaneous Transluminal Renal Angioplasty in Renovascular Hypertension.  310:322-323. 1984

B-Cell Abnormalities in AIDS.  310:258-259. 1984

Hyperthyroxinemia in Newborns Due to Excess Thyroxine-Binding Globulin.  309:897-899. 1983

Percutaneous Transluminal Renal Angioplasty in Renovascular Hypertension Due to Atheroma or Fibromuscular Dysplasia.  309:274-279. 1983

Caring for Other Physicians.  308:1542-1543. 1983

End-Stage Renal Disease in Systemic Lupus Erythematosus.  308:1537-1539. 1983

Microbiologic Study of Infertile Women at the Time of Diagnostic Laparoscopy: Association of Ureaplasma Urealyticum with a Defined Subpopulation.  308:502-505. 1983

Vidarabine for Herpes Zoster.  308:526-527. 1983

DNA Restriction-Enzyme Analysis of Herpes Simplex Virus Isolates Obtained from Patients with Encephalitis.  307:1060-1062. 1982

Early Vidarabine Therapy to Control the Complications of Herpes Zoster in Immunosuppressed Patients.  307:971-975. 1982

False-Negative Results with Levodopa for Early Detection of Huntington's Disease.  307:561-562. 1982

Racial Differences in the Incidence of Treatment for End-Stage Renal Disease.  306:1276-1279. 1982

Properdin Deficiency with IgA Nephropathy.  305:1097. 1981

Correlation of Spectral Phonoangiography and Carotid Angiography with Gross Pathology in Carotid Stenosis.  305:417-419. 1981

Herpes Simplex Encephalitis.  304:1236-1237. 1981

Herpes Simplex Encephalitis: Vidarabine Therapy and Diagnostic Problems.  304:313-318. 1981

Operative Risk Factors in Patients with Left Main Coronary-Artery Disease.  303:953-957. 1980

Cimetidine for Prevention of Acute Gastrointestinal Bleeding.  303:108-110. 1980

HLA in Juvenile Diabetes.  302:405-406. 1980

Secondary Spread of H. influenzae.  301:1448-1449. 1979

Treatment of Hyperuricemia and Gout.  301:1240-1241. 1979

Fc-receptor dysfunction in lupus..  300:1487. 1979

Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus.  300:518-523. 1979

Treatment of Lupus Nephritis with Combined Therapy.  300:564-565. 1979

Fetal Bladder-Neck Obstruction and Elevated Amniotic-Fluid Alpha Fetoprotein.  297:1351. 1977

Ara-A for Herpes Encephalitis.  297:1288-1290. 1977

Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex Encephalitis: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study.  297:289-294. 1977

Evaluation of Tetracycline or Penicillin and Ampicillin for Treatment of Acute Pelvic Inflammatory Disease.  296:1380-1383. 1977

Aspirin and Renal Function.  296:1168-1169. 1977

Aspirin-Induced Depression of Renal Function.  296:418-424. 1977

CT-Scan Symbols.  295:1262. 1976

Vinblastine or Vincristine?.  295:677. 1976

Adenine Arabinoside Therapy of Herpes Zoster in the Immunosuppressed: NIAID Collaborative Antiviral Study.  294:1193-1199. 1976

Treatment of Hydrazine-Induced Coma with Pyridoxine.  294:938-939. 1976

The Renin-Angiotensin System.  291:446-457. 1974

The Renin-Angiotensin System.  291:389-401. 1974

The renin-angiotensin system (first of two parts)..  291:389-401. 1974

Estrogen Binding in Breast Cancer.  290:914. 1974

Antenatal Detection of the Sphingolipidoses.  288:1405-1406. 1973

Left-Superior-Vena-Cava Steal Syndrome.  286:303-304. 1972

Infantile and Adult-Onset Metachromatic Leukodystrophy: Biochemical Comparisons and Predictive Diagnosis.  285:785-787. 1971

Failure of Isoprinosine in Amyotrophic Lateral Sclerosis.  285:689. 1971

Carbenicillin — Gentamicin.  285:411-412. 1971

Pathogenesis of hyperuricemia in saturinine gout..  280:1199-1202. 1969

Primary cutaneous tuberculosis resulting from mouth-to-mouth respiration..  273:1035-1036. 1965